ONC compared with BIDU: revenue, margins and what each company keeps, and the suppliers and customers both name

ONCBeOne Medicines Ltd.

Mkt capRevenueRevenue

BIDUBaidu, Inc.

Mkt capRevenueRevenue

Compare

ONCBeOne Medicines Ltd.

BIDUBaidu, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

ONC1 of 4 reports

Reportimpliedrealized× implied

Q2 FY26—▼−0.15%—

BIDU

No earnings history for BIDU.

= impliedONC realized, solidBIDU realized, hatchedOne scale, both sides: full bar = 1%× = |realized| ÷ impliedSource: market data

ONCBeOne Medicines Ltd.

368.02▼−0.62%· post 361.81· delayed

Mkt cap$42.1BRevenue$1.7BQ2 FY26Revenue$5.3BFY25

BIDUBaidu, Inc.

76.94▲+0.70%· post 77.00· delayed

After hoursNov 2 '26delayed

Mkt cap$419.3BRevenue—Revenue—

Compare

After hoursNov 2 '26delayed

ONCBeOne Medicines Ltd.

BIDUBaidu, Inc.

368.02▼−0.62%post 361.81delayed

Price

76.94▲+0.70%post 77.00delayed

$42.1B

Mkt cap

$419.3B

Q2 FY26$1.7B

Revenue

—

FY25$5.3B

Revenue

—

ONC368.02▼−0.62%vsBIDU76.94▲+0.70%After hoursNov 2 '26delayed